Pig kidney transplant study for people on dialysis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new type of kidney transplant using a genetically modified pig kidney (called a xenograft). It is for people with end-stage kidney disease who have been on dialysis and are not likely to get a human donor kidney soon. The goal is to see if this pig kidney can work safely as an alternative.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on dialysis for at least 6 months.
- Your doctors agree you are eligible for a kidney transplant.
- You are unlikely to get a standard deceased-donor kidney within the next year.
- Your blood type and immune system must match the study kidney.
- You have had the Epstein-Barr virus (common in most adults).
- You are up to date on recommended vaccines and can commit to lifelong follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether Envarsus XR helps prevent “subclinical” (not obviously noticeable) kidney transplant rejection by changing blood immune test results. You may be able to join if you recently received a kidney transplant and can take the study medicine as required.
This trial studies whether it’s safe and effective for HIV-positive people to receive organ transplants from HIV-positive donors. It focuses on matching HIV treatment before and after transplant and checking for major complications.
This trial tests a specially edited donor kidney designed to reduce the chance of rejection, especially for people with high sensitivity to donor kidneys. If it works, it could make more kidneys available for those who have a hard time finding a match.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This trial tests a genetically modified pig kidney (Thymokidney) for people with end-stage kidney disease who are on dialysis. It aims to see if this new type of transplant is safe and effective for those who cannot get a human kidney.
This study tests a program to help people with advanced kidney disease learn about and prepare for a kidney transplant. It is for patients who get kidney care at certain hospitals in New York and speak English or Spanish.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.